[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

UCB S.A. - Company Profile and SWOT Analysis

January 2024 | 49 pages | ID: UAE378B9004EN
MarketLine

US$ 175.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
UCB S.A. %li%Company Profile and SWOT Analysis

Summary

UCB S.A. %li%Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

UCB S.A. (UCB or ‘the company’) is a global biopharmaceutical company. It focuses on the discovery and development of medicines for people living with severe diseases in two therapeutic areas, immunology and neurology. UCB also offers a range of products for the treatment of patients with epilepsy, Parkinson’s disease, restless legs syndrome, axial spondyloarthritis, Crohn's disease, psoriatic arthritis, rheumotoid arthritis, Osteoporo, Lupus, and Psoriasis, among others. The company’s major brands include Cimzia, Vimpat, Keppra, Briviact, Neupro, Nayzilam, Evenity, Cirrus, Zyrtec, and Xyzal. The company operates across Europe, North America, and Asia-Pacific. The company is headquartered in Brussels, Belgium.

Scope
  • Detailed information on UCB S.A. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting UCB S.A. in the form of a SWOT analysis
  • An in-depth view of the business model of UCB S.A. including a breakdown and examination of key business segments
  • Intelligence on UCB S.A.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about UCB S.A., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
  • Gain understanding of UCB S.A. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess UCB S.A. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on UCB S.A.'s business structure, strategy and prospects.
Table of Contents
Company Snapshot
UCB S.A.: Company Overview
UCB S.A.: Overview and Key Facts
UCB S.A.: Overview
UCB S.A.: Key Facts
UCB S.A.: Key Employees
UCB S.A.: Key Employee Biographies
UCB S.A.: Major Products and Services
UCB S.A.: Management Statement
UCB S.A.: Locations and Subsidiaries
UCB S.A.: Key Competitors
UCB S.A.: Company Analysis
UCB S.A.: Business Description
UCB S.A.: SWOT Analysis
UCB S.A.: SWOT Overview
UCB S.A.: Strengths
UCB S.A.: Weaknesses
UCB S.A.: Opportunities
UCB S.A.: Threats
UCB S.A.: Corporate Financial Deals Activity
UCB S.A.: Financial Deals Overview
UCB S.A.: Targets and Partners
UCB S.A.: Top Deals 2020 - 2024YTD*
UCB S.A.: Advisors
UCB S.A.: Top Legal Advisors
UCB S.A.: Top Financial Advisors
UCB S.A.: Mergers and Acquisitions
UCB S.A.: Corporate Venturing
UCB S.A.: Capital Raising
UCB S.A.: Partnership
UCB S.A.: Divestments
UCB S.A.: Recent Developments
UCB S.A.: News and Events Summary
UCB S.A.: Contracts
UCB S.A.: Corporate Governance
UCB S.A.: Financial Deals
UCB S.A.: Financial Performance
UCB S.A.: Market Developments
UCB S.A.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

LIST OF TABLES

Table 1: UCB S.A.: Key Facts
Table 2: UCB S.A.: Key Employees
Table 3: UCB S.A.: Locations and Subsidiaries
Table 4: UCB S.A.: Key Competitors
Table 5: UCB S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: UCB S.A.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 7: UCB S.A.: M&A Average Deal Size - Value (US$m)
Table 8: UCB S.A.: Targets and Partners
Table 9: UCB S.A.: Top Deals 2020 - 2024YTD*
Table 10: UCB S.A.: Legal Advisor Ranking by Value (US$m)
Table 11: UCB S.A.: Financial Advisor Ranking by Value (US$m)
Table 12: UCB S.A.: M&A Volume and Value Trend (2020 - YTD*2024)
Table 13: UCB S.A.: M&A Activity by Geography (2020 - YTD*2024)
Table 14: UCB S.A.: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
Table 15: UCB S.A.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Table 16: UCB S.A.: Capital Raising by Deal Type (2020 - YTD*2024)
Table 17: UCB S.A.: Partnership Volume and Value Trend (2020 - YTD*2024)
Table 18: UCB S.A.: Partnership Trend by Deal Type (2020 - YTD*2024)
Table 19: UCB S.A.: Divestments Volume and Value Trend (2020 - YTD*2024)
Table 20: UCB S.A.: News and Events Summary
Table 21: UCB S.A.: Contracts
Table 22: UCB S.A.: Corporate Governance
Table 23: UCB S.A.: Financial Deals
Table 24: UCB S.A.: Financial Performance
Table 25: UCB S.A.: Market Developments
Table 26: UCB S.A.: Research & Development

LIST OF FIGURES

Figure 1: UCB S.A.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: UCB S.A.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 3: UCB S.A.: M&A Average Deal Size - Value (US$m)
Figure 4: UCB S.A.: M&A Volume and Value Trend (2020 - YTD*2024)
Figure 5: UCB S.A.: M&A Activity by Geography (2020 - YTD*2024)
Figure 6: UCB S.A.: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
Figure 7: UCB S.A.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Figure 8: UCB S.A.: Capital Raising by Deal Type (2020 - YTD*2024)
Figure 9: UCB S.A.: Partnership Volume and Value Trend (2020 - YTD*2024)
Figure 10: UCB S.A.: Partnership Trend by Deal Type (2020 - YTD*2024)
Figure 11: UCB S.A.: Divestments Volume and Value Trend (2020 - YTD*2024)


More Publications